Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Numerous number of evidences show that high on-treatment platelet reactivity is a well-known risk factor for adverse events in patients after percutaneous coronary intervention (PCI). Controversial situations still exist regarding the effectiveness of tailoring antiplatelet therapy according to plat...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zhenhua Xing, Liang Tang, Zhaowei Zhu, Jiabing Huang, Xiaofan Peng, Xinqun Hu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2018-08-01
Schriftenreihe:	Platelets
Schlagworte:	all-cause mortality major adverse cardiac events (mace) major bleeding events meta-analysis percutaneous coronary intervention (pci) platelet reactivity
Online-Zugang:	http://dx.doi.org/10.1080/09537104.2017.1349306
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!